# Lisinopril and Hydrochlorothiazide

NDC: 68788-8253
Generic name: Lisinopril and Hydrochlorothiazide Tablets
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20221001

FDA application: ANDA076230

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- LISINOPRIL: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8253"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8253
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc4d7d0e-78a6-4d7e-ba53-aeeb008aa2dc